A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los Ángeles García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Dairon Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Olivia Fernández-Medina, Anet Valdés-Zayas, Guang-Wu Chen, Luís Herrera-Martínez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo

Open source

DOI: 10.1016/j.lana.2021.100079
Published: 12
Container: The Lancet Regional Health. Americas
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lana.2021.100079,
  title = {A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial},
  author = {Arturo Chang-Monteagudo and Rolando Ochoa-Azze and Yanet Climent-Ruiz and Consuelo Macías-Abraham and Laura Rodríguez-Noda and Carmen Valenzuela-Silva and Belinda Sánchez-Ramírez and Rocmira Perez-Nicado and Tays Hernández-García and Ivette Orosa-Vázquez and Marianniz Díaz-Hernández and María de los Ángeles García-García and Yanet Jerez-Barceló and Yenisey Triana-Marrero and Laura Ruiz-Villegas and Luis Dairon Rodríguez-Prieto and Rinaldo Puga-Gómez and Pedro Pablo Guerra-Chaviano and Yaíma Zúñiga-Rosales and Beatriz Marcheco-Teruel and Mireida Rodríguez-Acosta and Enrique Noa-Romero and Juliet Enríquez-Puertas and Delia Porto-González and Olivia Fernández-Medina and Anet Valdés-Zayas and Guang-Wu Chen and Luís Herrera-Martínez and Yury Valdés-Balbín and Dagmar García-Rivera and Vicente Verez-Bencomo},
  year = {2021},
  journal = {The Lancet Regional Health. Americas},
  doi = {10.1016/j.lana.2021.100079},
  url = {https://doi.org/10.1016/j.lana.2021.100079}
}

RIS

TY  - JOUR
TI  - A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
AU  - Arturo Chang-Monteagudo
AU  - Rolando Ochoa-Azze
AU  - Yanet Climent-Ruiz
AU  - Consuelo Macías-Abraham
AU  - Laura Rodríguez-Noda
AU  - Carmen Valenzuela-Silva
AU  - Belinda Sánchez-Ramírez
AU  - Rocmira Perez-Nicado
AU  - Tays Hernández-García
AU  - Ivette Orosa-Vázquez
AU  - Marianniz Díaz-Hernández
AU  - María de los Ángeles García-García
AU  - Yanet Jerez-Barceló
AU  - Yenisey Triana-Marrero
AU  - Laura Ruiz-Villegas
AU  - Luis Dairon Rodríguez-Prieto
AU  - Rinaldo Puga-Gómez
AU  - Pedro Pablo Guerra-Chaviano
AU  - Yaíma Zúñiga-Rosales
AU  - Beatriz Marcheco-Teruel
AU  - Mireida Rodríguez-Acosta
AU  - Enrique Noa-Romero
AU  - Juliet Enríquez-Puertas
AU  - Delia Porto-González
AU  - Olivia Fernández-Medina
AU  - Anet Valdés-Zayas
AU  - Guang-Wu Chen
AU  - Luís Herrera-Martínez
AU  - Yury Valdés-Balbín
AU  - Dagmar García-Rivera
AU  - Vicente Verez-Bencomo
PY  - 2021
JO  - The Lancet Regional Health. Americas
DO  - 10.1016/j.lana.2021.100079
UR  - https://doi.org/10.1016/j.lana.2021.100079
ER  -

APA

Chang-Monteagudo, A., Ochoa-Azze, R., Climent-Ruiz, Y., Macías-Abraham, C., Rodríguez-Noda, L., Valenzuela-Silva, C., Sánchez-Ramírez, B., Perez-Nicado, R., Hernández-García, T., Orosa-Vázquez, I., Díaz-Hernández, M., García-García, M. D. L. Á., Jerez-Barceló, Y., Triana-Marrero, Y., Ruiz-Villegas, L., Rodríguez-Prieto, L. D., Puga-Gómez, R., Guerra-Chaviano, P. P., Zúñiga-Rosales, Y., Marcheco-Teruel, B., Rodríguez-Acosta, M., Noa-Romero, E., Enríquez-Puertas, J., Porto-González, D., Fernández-Medina, O., Valdés-Zayas, A., Chen, G., Herrera-Martínez, L., Valdés-Balbín, Y., García-Rivera, D., & Verez-Bencomo, V. (2021). A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial. The Lancet Regional Health. Americas. https://doi.org/10.1016/j.lana.2021.100079

Source records

doaj · retrieved 2026-09-27T03:48:12.286Z